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Background: Hypertension, a worldwide public health problem, is a major risk factor for cardiovascular and kidney
disease, and the medical and economic burden of hypertension is increasing. Auricular acupuncture has been used
to treat various diseases, including hypertension. Several studies have shown that auricular acupuncture treatment
decreases blood pressure in patients with hypertension; however, the scientific evidence is still insufficient.
Therefore, we aimed to perform a randomised controlled clinical trial in patients with prehypertension and stage 1
hypertension to evaluate the effect and safety of auricular acupuncture.
Methods/designs: This on-going study is a two parallel arm, assessor-blinded, randomised controlled trial. Sixty
participants with prehypertension and stage 1 hypertension will be recruited and randomly allocated into two
groups in a 1:1 ratio. Participants in the auricular acupuncture group will receive auricular acupuncture treatment
two times per week for 4 weeks. Participants in the usual care group will not receive any acupuncture treatment
during the study period. All participants in both groups will be provided with verbal and written educational
materials regarding the dietary and physical activity habits for controlling high blood pressure, and they will self-
manage their lifestyle, including diet and exercise, during the study. The primary outcome is the 24-h average
systolic and diastolic blood pressure, as measured with an ambulatory monitor. The secondary outcomes are the
mean change in the average systolic and diastolic blood pressure during day- and night-time, the circadian rhythm
of blood pressure, the mean arterial pressure, the change in blood pressure before and after auricular acupuncture
treatment, the EuroQOL-5D (EQ-5D), heart rate variability (HRV), body mass index (BMI) and laboratory examination,
including lipid profile and high sensitivity C-reactive protein (hs-CRP). Safety will be assessed at every visit.
Discussion: This pilot multicentre randomised controlled trial will explore the feasibility of further auricular
acupuncture research and provide important clinical evidence for the effect and safety of auricular acupuncture on
blood pressure in patients with prehypertension and stage 1 hypertension compared with usual care.
Trial registration: Clinical Research Information Service: KCT0000169
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Hypertension, a worldwide public health problem, is a
major risk factor for cardiovascular and kidney disease.
The prevalence and global burden of the disease are in-
creasing [1]. Stage 1 hypertension is systolic blood pres-
sure (SBP) varying from 140 to 159 mmHg or diastolic
blood pressure (DBP) varying from 90 to 99 mmHg, and
it is a common form of hypertension. The Seventh Report
of the Joint National Committee on Prevention, Detection,
Evaluation and Treatment of High Blood Pressure (JNC7)
defined prehypertension as SBP of 120 to 139 mmHg and
DBP of 80 to 89 mmHg to identify individuals who were
associated with a risk of developing hypertension and de-
crease blood pressure (BP), inhibit the progression of BP
to hypertensive levels with age and prevent hypertension
through early intervention [2].
The current treatments for hypertension include several
classes of antihypertensive drugs and strategies to modify
the effect of adverse lifestyles on blood pressure. Non-
pharmacological interventions, including weight loss, re-
duced sodium intake, regular physical activity, smoking
cessation, and the moderation of alcohol intake, are
recommended [2,3]. Antihypertensive drugs, including
angiotensin-converting enzyme (ACE) inhibitors, angio-
tensin receptor blockers (ARBs), beta-blockers, calcium
channel blockers (CCBs), and thiazide-type diuretics, are
commonly used [2]. However, it is still controversial
whether antihypertensive drug therapy is needed for
persons with prehypertension [4,5] and mild hyperten-
sion [6,7]. Long-term compliance with lifestyle modifi-
cations is also difficult for the patient.
Acupuncture has been widely used to treat various
conditions, including cardiovascular disease and hyper-
tension [8]. The mechanisms underlying the BP-lowering
effect of acupuncture are associated with the control of
BP modulators such as renin [9], aldosterone [10], angio-
tensin II [11] and endothelin-1 [12], and neurotransmitter
modulation such as glutamate, GABA, serotonin and
endocannabinoids [13]. Of three high-quality, randomised,
controlled trials, two showed a positive effect on BP
[14,15], but one trial reported a non-significant BP reduc-
tion between the groups [16]. Auricular acupuncture is
one type of acupuncture based on the understanding that
the external ear represents all parts of the human body,
including the internal organs, and provides acupuncture
points corresponding to these parts [17,18]. Several arti-
cles have evaluated the effect of auricular acupuncture on
controlling BP [19-22]. Some studies also reported that
the electroacupuncture treatment of auricular acupoints
decreased BP in patients with hypertension [23,24].
However, the scientific evidence is insufficient [25].
Most previous studies have some methodological limi-
tations, including low quality of the study design, small
sample size, inadequate control groups, and a lack ofsuitable outcome measures. In addition, there is no
clinical trial evaluating the effect of auricular acupunc-
ture on prehypertension. Safe and effective interven-
tions that are able to manage pre/mild hypertension
would be desirable. Therefore, more rigorous studies
are needed to elucidate the effect and safety of auricu-
lar acupuncture on pre/mild hypertension.
In the present study, we aimed to perform a randomised
controlled clinical trial in patients with prehypertension
and stage 1 hypertension to evaluate the effect and safety
of auricular acupuncture compared with usual care. The
24-h ambulatory blood pressure will be used as the pri-
mary endpoint. The results derived from this study will
also be used to explore the feasibility of auricular acu-
puncture treatment and calculate the appropriate sample
size for a future large clinical trial.
Methods/design
Study design
This study is a two parallel arm, assessor-blinded,
randomised controlled trial. The trial will be performed at
two clinical research centres in Korea in accordance with
the Declaration of Helsinki and the Guidelines for Good
Clinical Practice: the Korea Institute of Oriental Medicine
(Daejeon University Hospital) and Dongguk University
Ilsan Oriental Hospital. This protocol was registered with
the ‘Clinical Research Information Service’, Republic of
Korea, which is a registry in the WHO Registry Network.
Eligible participants will be stratified by centre, age, and
sex and randomly allocated into one of the two groups (the
auricular acupuncture group or the usual care group) at a
1:1 allocation ratio and receive treatment for 4 weeks, with
2 months of follow-up (Figure 1). The evaluation of partici-
pants and the analysis of the results will be performed by
professionals blinded to the group allocation.
Participants
Inclusion criteria
A total of 60 patients will be recruited through local ad-
vertising and from the outpatients of the two hospitals.
The eligibility criteria for the study include age 19 to 65
years; prehypertension (SBP of 120–139 mmHg or DBP
of 80–89 mmHg) or stage 1 hypertension (SBP of 140–
159 mmHg or DBP of 90–99 mmHg) according to JNC
7 criteria; and signed written informed consent. After
providing consent, the blood pressure of potential sub-
jects will be measured three times. Patients will be eli-
gible for inclusion in the study if the average of three
systolic or diastolic pressure measurements is within the
specified intervals.
Exclusion criteria
Participants will be excluded if they are experiencing or have
a history of the following: currently taking antihypertensive
Figure 1 A flowchart of the study.
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controlling blood pressure; secondary hypertension; cerebro-
vascular or cardiovascular disease history; malignant cancer
history; diabetes mellitus requiring medication or insulin in-
jection; disease history, including renal diseases, hepatic
diseases, thyroid diseases, active tuberculosis, and other in-
fectious diseases; haemorrhagic diseases or taking anticoag-
ulants; T-needle allergy; local infection at the ear; systemic
steroid therapy or immune depressants; medications that
may affect blood pressure, such as oral contraceptives, cen-
tral nervous system depressants or stimulants; pregnant or
breast-feeding women or women who plan to become
pregnant; the use of traditional Korean medicinal treat-
ment during the last 1 month; or inappropriate for this trial
for other reasons, including unwillingness to comply with
this study protocol or inability to complete the study-
related questionnaires by themselves or with assistance, as
decided by researchers.
Randomisation
Study participants who meet the eligibility criteria will
be randomly assigned to two groups (the auricular acu-
puncture group or the usual care group) at the second
visit through central randomisation in a 1:1 ratio. Ran-
domisation will be conducted using a computer-generated
random allocation sequence through the stratified block
randomisation method of the SAS package (version 9.1.3;
SAS Institute, Inc., Cary, NC, USA) by a statistician withno clinical involvement in this trial, and the patients will
be stratified by centre, age (19–30, 31–40, 41–50, 51–65
years) and sex.
Allocation concealment will be ensured, as the ran-
domisation code will be released after the participants
are recruited into the trial and all baseline measures are
taken. The subjects and practitioners will be aware of
the allocation arm according to the routine care setting.
However, the outcome assessors and the statistician
performing the data analyses will be masked to the treat-
ment allocation [26].
Intervention
Auricular acupuncture treatment group
Patients in the auricular acupuncture group will receive
auricular acupuncture treatment twice a week for 4
weeks. Auricular acupuncture, which is attached to the
skin, will be used for this trial, and Haeng Rim T-needles
(Haeng Rim Seo Won Medical Co., Korea) will be adopted
for intervention. The acupuncture points were selected by
an expert committee composed of professors and re-
searchers who specialise in traditional Korean medicine
on the basis of a literature review [20,22] and a textbook
[17] about acupuncture for blood pressure. At every visit,
after the acupuncture points have been sterilised with 75%
alcohol preparation pads, T-needles will be applied to six
ear acupuncture points: the ear apex point (HX6, 7i), the
endocrine point (CO 18), the shen men point (TF4), the
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(CO15), and the groove of the posterior surface point
(PS). Attached T-needles should be maintained for 3–4
days and then removed. In addition, T-needles will be at-
tached on one ear in the first session and the opposite ear
in the next session, alternating thereafter.
The auricular acupuncture treatment will be conducted
by doctors of Korean medicine who are certified by the
Korean Ministry of Health and Welfare with at least 4
years of clinical experience and who have received more
than 6 years of oriental medicine college education. They
will take a 1-day training course for this trial, and the
techniques for auricular acupuncture treatment will be
standardised between practitioners. In addition, all study
protocols and details, including the recording method for
the clinical record form, outcome assessment methods,
and monitoring process, will be standardised between the
two centres through workshops before the beginning of
the study. Additional treatment, including antihyperten-
sive drugs and treatment with traditional Korean medi-
cine, will not be allowed during the trial.
Usual care group
Subjects randomised to the usual care group will not be
given auricular acupuncture treatment. However, partici-
pants in both groups will be provided with verbal and
written educational materials regarding dietary and
physical activity habits for controlling high blood pres-
sure and self-manage their lifestyle, including diet and
exercise, during the study. Additional treatment, includ-
ing antihypertensive drugs and treatment with trad-
itional Korean medicine, will be prohibited, and any
violations will be recorded.
Outcome
Primary outcome measurement
The primary outcome measure is the 24-h mean systolic
and diastolic blood pressure. The subjects will undergo
24-h ambulatory blood pressure monitoring (PressureTrak
Oscillometric Ambulatory Blood Pressure Monitor,
SunTech, Morrisville, NC, USA), and the monitor
will be programmed to record blood pressure mea-
surements twice per hour during daytime (7 a.m. to
10 p.m.) and once per hour during night-time (10 p.m. to
7 a.m.). The mean systolic and diastolic blood pressure
during the entire 24-h monitoring period will be used in
the data analysis.
Secondary outcome measurements
We will assess the mean change in the mean systolic
and diastolic blood pressure during daytime and night-
time. The participants will be instructed to fill out a
diary to record the time of sleeping and rising, and the
readings will be divided into daytime and night-timevalues according to individual wake times and bedtimes.
In addition to the mean systolic and diastolic blood
pressure, the circadian rhythm of blood pressure and the
mean arterial pressure will also be evaluated.
The change in blood pressure before and after auricu-
lar acupuncture treatment will be assessed. Blood pres-
sure will be observed and recorded at every visit. At
every visit, the brachial blood pressure will be measured
three times in at least 1-min intervals using an auto-
matic blood pressure monitor (FT-700 R; Jawon medical,
Kungsan-city, Korea) with the subjects resting for at
least 5 min in a quiet and temperature-controlled room
with their upper arm at heart level. Subjects will be
instructed not to drink caffeinated drinks such as coffee
or tea and not to exercise, smoke, or eat 2 h before the
blood pressure test [27]. The mean of these three mea-
surements will be used in the data analysis.
The EuroQOL-5D (EQ-5D) will be used to evaluate
health-related quality of life (HRQOL). The EQ-5D
questionnaire is the most widely used instrument to
measure health status, and it assesses scores across five
dimensions of health: mobility, self-care, usual activ-
ities, pain or discomfort, and anxiety or depression.
Each dimension is divided into three categories: no
problems, some problems, and extreme problems. The
Korean version of the EQ-5D has been developed, and
its validity and reliability have been demonstrated [28].
Heart rate variability (HRV) is a useful non-invasive
tool to investigate the sympathetic and parasympathetic
function of the autonomic nervous system and cardiac
autonomic dysregulation in hypertension. An SA-6000
(Medicore Co. Ltd., Seoul, Korea) will be used for study-
ing HRV. The results, including the standard deviation
of all of the normal-to-normal intervals (SDNN), the
square root of the mean squared differences of succes-
sive normal-to-normal intervals (RMSSD), the percent-
age of successive normal interbeat intervals greater than
50 ms (pNN50), the very low frequency (VLF), low fre-
quency (LF), high frequency (HF), total power (TP), LF/
HF ratio, heart rate, and HRV index, will be analysed at
baseline and 5 and 13 weeks after baseline. This test will
be performed at DongGuk University Ilsan Oriental
Hospital only.
BMI (body mass index) is the most commonly used in-
dicator of obesity and is determined from height and
weight. In this trial, BMI will be assessed at baseline and
5 and 13 weeks after baseline.
Laboratory examination will be performed for the lipid
profile, hs-CRP, fasting blood glucose, and uric acid. The
lipid profile measures total cholesterol, HDL cholesterol,
LDL cholesterol, and triglyceride levels. Blood samples
will be collected after overnight fasting at baseline and
at weeks 5 and 13. An overview of the outcome meas-
urement time points is presented in Table 1.
Table 1 Schedule for treatment and outcome measurements
Period S T F
Visit 1 2 3 4 5 6 7 8 9 10 11




Auricular acupuncture treatment ○ ○ ○ ○ ○ ○ ○ ○
BP before and after auricular acupuncture treatment ○ ○ ○ ○ ○ ○ ○ ○
24-h ABPM ● ● ● ●
Laboratory examination ● ● ●
BMI ● ● ● ●
EQ-5D ● ● ●
Heart rate variability ● ● ●
Safety assessment ● ○ ○ ○ ○ ○ ○ ○ ● ●
S Screening period, T treatment period, F follow-up period, BP blood pressure, ABPM ambulatory blood pressure monitoring, BMI body mass index, EQ-5D
EuroQOL-5D.
●: Both the auricular acupuncture group and the usual care group.
○: Only the auricular acupuncture group.
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There is a growing body of research evaluating the effect
of acupuncture for various diseases, including hyperten-
sion. However, there is still a lack of studies evaluating
the effect of auricular acupuncture on prehypertension
or stage 1 hypertension. There is no previous study on
which to base the sample size calculation. The current
study is designed as a pilot study to determine initial
data for the primary outcome measure to perform a
sample size calculation for a large-scale randomised con-
trolled trial. Each group will include 30 participants,
which is the minimum sample size for evaluating the ef-
fect of auricular acupuncture. More than 80% of all eli-
gible patients can be recruited, and more than 80% of all
randomised patients have to complete the scheduled
treatments, assessments, and follow-up [29-31].Statistical analysis
All analyses will be performed with SAS (version 9.1.3;
SAS Institute, Inc., Cary, NC, USA) by a statistician
blinded to the allocation of groups. Statistical analysis
will be undertaken on the intent-to-treat (ITT) basis
with a 95% confidence interval using multiple imputa-
tions. The ITT analysis will include all patients who are
randomised [32], and the per-protocol (PP) analysis will
include patients who complete the study and do not
have major protocol violations [33]. All analyses will be
based on the ITT population, and the result of the ITT
analysis will be compared with the PP analysis to assess
the sensitivity.
Analysis of covariance (ANCOVA) with the baseline
score as a covariate for the whole subject pool will be usedto assess differences in treatment outcomes between the
two groups at each of these time points as a main analysis.
The results for the applicable stratified groups with centre,
age, and sex as stratified variables will be assessed as add-
itional analyses. The repeated measures analysis of vari-
ance will be performed for the different time point
assessments.Adverse events
Any expected or unexpected adverse events will be
reported by the participants and practitioners at every
visit and followed up to completion. The adverse events
known to be related to auricular acupuncture treatment
include local bleeding or pain at the needle insertion
points, local redness, itching, and dizziness during treat-
ment and the follow-up period [17]. If any adverse events
occur, the patient will be provided appropriate treatment.
Serious adverse events will be reported to the principal in-
vestigator immediately, and the patient will be withdrawn
from the clinical trial; details, including the date of occur-
rence, lost time, measures taken related to the treatment,
causal relationship with the treatment, and treatment of
the adverse event, will be recorded.Ethics
This research protocol has been reviewed and approved
by the institutional review boards of each trial centre
(Daejeon University Hospital [djomc-72] and DongGuk
University Ilsan Oriental Hospital [2011–15]). Written
informed consent will be obtained from all study partici-
pants prior to enrolment into the study.
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The initial management of hypertension begins with a
diagnosis based on several blood pressure measurements
made in the clinic. Ambulatory blood pressure (ABP) is
a more accurate measure of BP compared with clinical
BP and shows better correlation with cardiovascular out-
comes and target organ damage [34-36]. Some studies
also suggest that adopting ABP monitoring as the refer-
ence standard for the diagnosis of hypertension would
lead to more appropriately targeted treatment, and this
would be particularly important for patients near the
threshold for diagnosis [37,38]. Therefore, we will use
ABP as a primary outcome measurement to assess the
effect of auricular acupuncture on prehypertension and
stage 1 hypertension. The clinical blood pressure will be
assessed as a secondary outcome measurement.
Blood pressure is a surrogate end point, and the relation-
ship between blood pressure and the risk of morbid cardio-
vascular events is well established [39,40]. The present
pilot study will provide data on the effectiveness of auricu-
lar acupuncture for reducing blood pressure and the dur-
ation of therapy through a follow-up period of 2 months
after the completion of the treatment. An assessment
of reductions in clinical outcomes, such as cardiovas-
cular events, stroke, and coronary heart disease, and
the prevention of progression from prehypertension to
stage 1 hypertension will be needed in a future long-
term clinical trial.
In addition to appropriate outcome measures, the use
of an appropriate control group is a critical issue in de-
signing a high-quality clinical trial. In prehypertension
and mild hypertension, lifestyle modification is the first
line and an essential step for lowering blood pressure be-
fore starting lifelong antihypertensive medication [2,4].
The purpose of this study is to clarify whether acupunc-
ture is effective in controlling the blood pressure of pa-
tients with pre- and mild hypertension if implemented
in real-world clinical conditions, and we have planned a
pragmatic design using usual care as the control group.
A pragmatic clinical trial can provide evidence focussed
on the effectiveness of an additional treatment in a real-
world setting rather than the efficacy of a treatment in
an ideal experimental setting [41,42]. This pragmatic
comparison of acupuncture with usual care has some
limitations. First, not blinding the participants to the
intervention and potential placebo effects is related to
overestimation of intervention effects. Second, the inev-
itable difference in number of visits and clinic BP mea-
surements between the two groups can bias the result.
To minimise the confounding effects, any contact and
conversation not involved in acupuncture treatment be-
tween researchers and patients are prohibited, and there
is no mention of or advice on BP and lifestyle. The num-
ber of primary outcome measurements is identical in thetwo groups. Baseline characteristics, including smoking,
sodium intake, alcohol intake, and physical activity,
will be obtained and assessed in both groups. Patients’
pre-treatment expectations will be measured using a
modified question of the Treatment Expectancy Ques-
tionnaire, which is “How much do you feel auricular
acupuncture therapy will help to lower your blood
pressure?” This question will be scored on a 9-point
numeric rating scale (1 = not at all; 9 = very much)
[43-47]. The study results will be interpreted cautiously.
In conclusion, this pilot multicentre randomised con-
trolled trial will provide important clinical evidence for
the effect of auricular acupuncture on blood pressure in
patients with prehypertension and stage 1 hypertension
compared with usual care.
Trial status
The trial is currently in the recruitment phase, and 54
patients were recruited.
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